The traveling heads 2.0: Multicenter reproducibility of quantitative imaging methods at 7 Tesla.


Journal

NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515

Informations de publication

Date de publication:
15 05 2021
Historique:
received: 22 10 2020
revised: 25 01 2021
accepted: 20 02 2021
pubmed: 2 3 2021
medline: 15 10 2021
entrez: 1 3 2021
Statut: ppublish

Résumé

This study evaluates inter-site and intra-site reproducibility at ten different 7 T sites for quantitative brain imaging. Two subjects - termed the "traveling heads" - were imaged at ten different 7 T sites with a harmonized quantitative brain MR imaging protocol. In conjunction with the system calibration, MP2RAGE, QSM, CEST and multi-parametric mapping/relaxometry were examined. Quantitative measurements with MP2RAGE showed very high reproducibility across sites and subjects, and errors were in concordance with previous results and other field strengths. QSM had high inter-site reproducibility for relevant subcortical volumes. CEST imaging revealed systematic differences between the sites, but reproducibility was comparable to results in the literature. Relaxometry had also very high agreement between sites, but due to the high sensitivity, differences caused by different applications of the B1 calibration of the two RF coil types used were observed. Our results show that quantitative brain imaging can be performed with high reproducibility at 7 T and with similar reliability as found at 3 T for multicenter studies of the supratentorial brain.

Identifiants

pubmed: 33647497
pii: S1053-8119(21)00187-7
doi: 10.1016/j.neuroimage.2021.117910
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

117910

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflict of interest. Most of the institutes or sites involved in this study have or had and institutional research agreement with Siemens Healthcare. UHF adapted imaging sequences were provided by Siemens Healthcare GmbH. NW was a speaker at an event organized by Siemens Healthcare and was reimbursed for the travel expenses.

Auteurs

Maximilian N Voelker (MN)

Erwin L. Hahn Institute for Magnetic Resonance Imaging, University Duisburg-Essen, Essen, Germany; High-Field and Hybrid MR Imaging, University Hospital Essen, University Duisburg-Essen, Essen, Germany. Electronic address: Maximilian.Voelker@uni-due.de.

Oliver Kraff (O)

Erwin L. Hahn Institute for Magnetic Resonance Imaging, University Duisburg-Essen, Essen, Germany.

Steffen Goerke (S)

Division of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Frederik B Laun (FB)

Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Jannis Hanspach (J)

Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Kerrin J Pine (KJ)

Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

Philipp Ehses (P)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Moritz Zaiss (M)

Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Max Planck Institute for Biological Cybernetics, Tübingen, Germany.

Andrzej Liebert (A)

Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Sina Straub (S)

Division of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Korbinian Eckstein (K)

High Field MR Center, Department for Biomedical Imaging and Image guided Therapy, Medical University of Vienna, Vienna, Austria.

Simon Robinson (S)

High Field MR Center, Department for Biomedical Imaging and Image guided Therapy, Medical University of Vienna, Vienna, Austria.

Armin N Nagel (AN)

Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Maria R Stefanescu (MR)

Chair of Cellular and Molecular Imaging, Comprehensive Heart Failure Center (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.

Astrid Wollrab (A)

Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.

Sabrina Klix (S)

Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrueck-Center for Molecular Medicine, Berlin-Buch, Germany.

Jörg Felder (J)

Institute of Neuroscience and Medicine (INM-4), Forschungszentrum Jülich, Jülich, Germany.

Michael Hock (M)

Chair of Cellular and Molecular Imaging, Comprehensive Heart Failure Center (CHFC), University Hospital Wuerzburg, Wuerzburg, Germany.

Dario Bosch (D)

Max Planck Institute for Biological Cybernetics, Tübingen, Germany.

Nikolaus Weiskopf (N)

Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany; Felix Bloch Institute for Solid State Physics, Faculty of Physics and Earth Sciences, Leipzig University, Leipzig, Germany.

Oliver Speck (O)

Otto-von-Guericke-University Magdeburg, Magdeburg, Germany; Leibniz Institute for Neurobiology, Magdeburg, Germany.

Mark E Ladd (ME)

Erwin L. Hahn Institute for Magnetic Resonance Imaging, University Duisburg-Essen, Essen, Germany; Division of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and Faculty of Physics and Astronomy, Heidelberg University, Heidelberg, Germany.

Harald H Quick (HH)

Erwin L. Hahn Institute for Magnetic Resonance Imaging, University Duisburg-Essen, Essen, Germany; High-Field and Hybrid MR Imaging, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH